(AARD) Aardvark Therapeutics - Performance 7.5% in 12m
AARD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
4.30%
#58 in Peer-Group
Rel. Strength
69.84%
#2250 in Stock-Universe
Total Return 12m
7.48%
#56 in Peer-Group
Total Return 5y
7.48%
#62 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 17.25 USD |
| 52 Week Low | 7.00 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 68.46 |
| Buy/Sell Signal +-5 | -0.14 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AARD (7.5%) vs XLV (-7.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.67% | 143% | 342% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
9.25% | -11.8% | 416% | 63.7 | 36 | 1.2 | 58.2% | 18.9% |
| NVS NYSE Novartis |
4.23% | 13.9% | 74.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
1.41% | 2.61% | 46.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| GSK NYSE GlaxoSmithKline |
-2.94% | -0.85% | 47.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.61% | -1.2% | 117% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.8% | -10.9% | 47.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.16% | -10.2% | 43.5% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: AARD vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AARD
| Total Return (including Dividends) | AARD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 56.62% | 1.80% | 3.01% |
| 3 Months | 69.20% | -7.39% | 5.82% |
| 12 Months | 7.48% | -7.13% | 12.82% |
| 5 Years | 7.48% | 47.29% | 114.16% |
| Trend Score (consistency of price movement) | AARD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 62.3% | 54% | 78.3% |
| 3 Months | 79.3% | -57.4% | 87.1% |
| 12 Months | 5.9% | -69.2% | 43.5% |
| 5 Years | 5.9% | 88.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #6 | 53.85% | 52.05% |
| 3 Month | #9 | 82.69% | 59.90% |
| 12 Month | #55 | 16.49% | 7.30% |
| 5 Years | #26 | 16.49% | 7.30% |
FAQs
Does Aardvark Therapeutics (AARD) outperform the market?
Yes,
over the last 12 months AARD made 7.48%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.13%.
Over the last 3 months AARD made 69.20%, while XLV made -7.39%.
Performance Comparison AARD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AARD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 25.4% | 53.6% | 5.9% | -5% |
| US NASDAQ 100 | QQQ | 24.9% | 52.7% | 5% | -6% |
| German DAX 40 | DAX | 26.6% | 59.7% | -9.7% | -21% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 23.8% | 52.4% | 5.3% | -12% |
| Hongkong Hang Seng | HSI | 23% | 48.4% | -13.2% | -28% |
| India NIFTY 50 | INDA | 25.1% | 55.8% | 4.2% | 7% |
| Brasil Bovespa | EWZ | 29.1% | 56.3% | -16.1% | 1% |
AARD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 25.4% | 53% | 0.7% | -16% |
| Consumer Discretionary | XLY | 25.9% | 58.2% | 15.8% | -11% |
| Consumer Staples | XLP | 26.9% | 58.5% | 5.6% | 1% |
| Energy | XLE | 30.6% | 53.6% | 5.9% | 12% |
| Financial | XLF | 24.6% | 55.3% | 2.1% | -19% |
| Health Care | XLV | 26.3% | 54.8% | 10.7% | 15% |
| Industrial | XLI | 25.9% | 56% | -0.3% | -12% |
| Materials | XLB | 27% | 56.6% | 4.8% | 8% |
| Real Estate | XLRE | 27.9% | 55.9% | 5% | -5% |
| Technology | XLK | 24% | 49.1% | 3.5% | -3% |
| Utilities | XLU | 26.7% | 57.4% | 0.5% | -12% |
| Aerospace & Defense | XAR | 24.7% | 51.9% | -11% | -37% |
| Biotech | XBI | 26.6% | 51.6% | 17.6% | 18% |
| Homebuilder | XHB | 23.3% | 56.4% | 15.9% | 11% |
| Retail | XRT | 26.8% | 56.3% | 13.5% | 5% |
AARD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 38.2% | 47.7% | 7.23% | 15% |
| Natural Gas | UNG | 39.7% | 63.8% | 4.4% | 24% |
| Gold | GLD | 28.3% | 55.8% | -18.9% | -36% |
| Silver | SLV | 28.1% | 47.4% | -14.2% | -18% |
| Copper | CPER | 25.6% | 52.5% | -11.7% | -6% |
AARD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 26.3% | 54.2% | 6.1% | 11% |
| iShares High Yield Corp. Bond | HYG | 26.6% | 55.2% | 3.3% | -2% |